Followers | 51 |
Posts | 1829 |
Boards Moderated | 0 |
Alias Born | 02/12/2022 |

Tuesday, July 26, 2022 3:40:00 PM
Recent GOVX News
- GeoVax COVID-19 Vaccine Clinical Data Presented at World Vaccine Congress • GlobeNewswire Inc. • 11/28/2023 02:00:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/27/2023 09:06:14 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/17/2023 09:27:05 PM
- Progress on GeoVax’s Universal Coronavirus Vaccine Candidate, GEO-CM02, Presented at Vaccines Summit 2023 • GlobeNewswire Inc. • 11/14/2023 02:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 05:40:58 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/08/2023 09:04:05 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/08/2023 09:03:04 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 11/08/2023 09:01:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 09:00:28 PM
- GeoVax Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/08/2023 09:00:00 PM
- GeoVax to Report Third Quarter 2023 Financial Results and Provide Corporate Update on November 8, 2023 • GlobeNewswire Inc. • 10/31/2023 01:00:00 PM
- GeoVax Commences Site Expansion for Phase 2 Trial of Next-Generation COVID-19 Vaccine • GlobeNewswire Inc. • 10/30/2023 01:00:00 PM
- GeoVax to Participate in Upcoming November Investor and Industry Events • GlobeNewswire Inc. • 10/25/2023 01:00:00 PM
- Clinical and Operational Progress Toward Transformative Opportunities • GlobeNewswire Inc. • 10/24/2023 01:00:00 PM
- GeoVax Receives Notice of Allowance for Marburg Vaccine Patent • GlobeNewswire Inc. • 10/09/2023 01:00:00 PM
- GeoVax Receives Notice of Allowance for HIV Vaccine Patent • GlobeNewswire Inc. • 10/05/2023 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/27/2023 08:33:08 PM
- GeoVax to Participate in Upcoming October Investor and Industry Events • GlobeNewswire Inc. • 09/27/2023 01:00:00 PM
- GeoVax Secures Multi-Product License for ProBioGen's AGE1.CR.pIX® Suspension Cell Line to Bolster MVA-Based Vaccine Development • GlobeNewswire Inc. • 09/26/2023 01:00:00 PM
- Dawson James Securities Announces October Date for 8th Annual Small Cap Growth Conference • GlobeNewswire Inc. • 09/21/2023 01:35:00 PM
- GeoVax Next-Generation COVID-19 Vaccine Data Presented at Keystone Symposia Conference • GlobeNewswire Inc. • 09/20/2023 01:00:00 PM
- GeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent Antibody and Cellular Immunity in Immunocompromised Patients • GlobeNewswire Inc. • 09/19/2023 01:00:00 PM
- GeoVax Presents Corporate Update at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 09/12/2023 01:00:00 PM
- GeoVax Completes Enrollment of Phase 2 Trial for Next-Generation COVID-19 Vaccine Booster • GlobeNewswire Inc. • 09/11/2023 01:00:00 PM
- GeoVax to Present at the H.C. Wainwright 25th Annual Global Investment Conference • GlobeNewswire Inc. • 08/31/2023 01:00:00 PM
FEATURED Major Triumph: Music Licensing, Inc. (OTC:SONG) Secures Coveted Royalty Stakes in Masterpieces by Elton John, Miley Cyrus, Lil Wayne, Lil Nas X, XXXTENTACION, & Halsey • Nov 27, 2023 9:00 AM
CGrowth Capital Inc. Sets Stage for Exciting 2024 with Savage Barbell Apparel Expansion • CGRA • Nov 28, 2023 11:15 AM
Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing • IMMX • Nov 28, 2023 10:48 AM
Swifty Global Secures GLI Certification for New Cutting-Edge B2B Gaming Platform • DRCR • Nov 28, 2023 9:15 AM
Nate's Food Co. Successfully Obtains GACC Registration in China, Paving the Way for Contract Execution on Commodities • NHMD • Nov 28, 2023 8:00 AM
Mass Megawatts Announces LOWEST PRICE GUARANTEE on Solar Project Sales and Further Cost Reductions Using our Patent Pending Technologies • MMMW • Nov 28, 2023 8:00 AM